comprehensive -WSS

comprehensive

author：explore 2025-09-28 18:59:24 - browse：53957

Senate Health, Education, Labor, and Pensions Chair Sen. Bernie Sanders, I-Vt., points toward a poster detailing what he said the U.S. versus the "Rest of the World" spends on prescription drugs, during a hearing to examine the cost of prescription drugs. -- health policy coverage — Sen. Bernie Sanders (I-Vt.) raises his hand at a Thursday hearing on Capitol Hill in Washington to examine the cost of prescription drugs. Jacquelyn Martin/AP

WASHINGTON — Call it Sen. Bernie Sanders’ prescription drug pricing theater.

The hearing, featuring Merck CEO Robert Davis, Johnson & Johnson CEO Joaquin Duato, and Bristol Myers Squibb CEO Chris Boerner, was designed to draw public interest, and in that respect, it worked. The wood-paneled hearing room in a Senate office building was standing room only, with an overflow room prepared. Photographers flocked for photos as Sanders shook hands with each executive, standard practice before such hearings begin.

Sanders’ staff got an arm workout switching out foam boards behind the chairman’s head, illustrating how the drug companies called to testify make more revenue from the United States on certain medications than the rest of the world combined.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： Experimental asthma app from Apple and Anthem shows promise

focus

knowledge

WSS

FDA reorg will put new emphasis on investigations, sources say

Readout Newsletter: Zepbound, Valneva's vaccine, and more

The story of mRNA: From a loose idea to a tool that may help curb Covid

Gene therapy has helped boys walk. Can scientists keep it that way?

CDC concerned about possible undetected monkeypox spread in U.K.

CVS, Rite Aid closures threaten to worsen pharmacy deserts

focus

comprehensive

knowledge

Novavax promises a turnaround & Lilly roils the obesity market

Medical school prerequisites are outdated

What does generative AI mean for health care? We asked experts

How state and local governments are sidelining science

As demand for Covid shots wanes, Moderna seeks its next success

Death of patient in Alzheimer’s trial raises question of possible risks

Medical leaders decry Supreme Court decision on affirmative action

Do masks work? RCTs can't tell us

Guidelines to prevent youth baseball injuries need more muscle

Publishing genetic code of viruses could cause disaster

focus

Death of patient in Alzheimer’s trial raises question of possible risks

Do masks work? RCTs can't tell us

FDA reorg will put new emphasis on investigations, sources say

A letter from the executive editor: STAT UnitedHealth investigation

Gene therapy has helped boys walk. Can scientists keep it that way?

The battle over the Brookhaven Landfill on Long Island

focus

focus

knowledge

hotspot